Author
Listed:
- Shunlei Duan
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Guohong Yuan
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Xiaomeng Liu
(Biodynamic Optical Imaging Center, College of Life Sciences, Peking University)
- Ruotong Ren
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences
FSU-CAS Innovation Institute
State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences)
- Jingyi Li
(Biodynamic Optical Imaging Center, College of Life Sciences, Peking University)
- Weizhou Zhang
(Carver College of Medicine, University of Iowa)
- Jun Wu
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Xiuling Xu
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Lina Fu
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Ying Li
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Jiping Yang
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Weiqi Zhang
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Ruijun Bai
(FSU-CAS Innovation Institute
State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences)
- Fei Yi
(Stanford University School of Medicine)
- Keiichiro Suzuki
(Gene Expression Laboratory, Salk Institute for Biological Studies
Universidad Católica San Antonio de Murcia (UCAM) Campus de los Jerónimos)
- Hua Gao
(Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University)
- Concepcion Rodriguez Esteban
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Chuanbao Zhang
(Beijing Institute for Brain Disorders)
- Juan Carlos Izpisua Belmonte
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Zhiguo Chen
(Cell Therapy Center, Xuanwu Hospital Capital Medical University)
- Xiaomin Wang
(Beijing Institute for Brain Disorders)
- Tao Jiang
(Beijing Institute for Brain Disorders)
- Jing Qu
(State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences)
- Fuchou Tang
(Biodynamic Optical Imaging Center, College of Life Sciences, Peking University
Ministry of Education Key Laboratory of Cell Proliferation and Differentiation
Center for Molecular and Translational Medicine, CMTM
Peking-Tsinghua Center for Life Sciences, Peking University)
- Guang-Hui Liu
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences
FSU-CAS Innovation Institute
Beijing Institute for Brain Disorders
Center for Molecular and Translational Medicine, CMTM)
Abstract
PTEN is a tumour suppressor frequently mutated in many types of cancers. Here we show that targeted disruption of PTEN leads to neoplastic transformation of human neural stem cells (NSCs), but not mesenchymal stem cells. PTEN-deficient NSCs display neoplasm-associated metabolic and gene expression profiles and generate intracranial tumours in immunodeficient mice. PTEN is localized to the nucleus in NSCs, binds to the PAX7 promoter through association with cAMP responsive element binding protein 1 (CREB)/CREB binding protein (CBP) and inhibits PAX7 transcription. PTEN deficiency leads to the upregulation of PAX7, which in turn promotes oncogenic transformation of NSCs and instates ‘aggressiveness’ in human glioblastoma stem cells. In a large clinical database, we find increased PAX7 levels in PTEN-deficient glioblastoma. Furthermore, we identify that mitomycin C selectively triggers apoptosis in NSCs with PTEN deficiency. Together, we uncover a potential mechanism of how PTEN safeguards NSCs, and establish a cellular platform to identify factors involved in NSC transformation, potentially permitting personalized treatment of glioblastoma.
Suggested Citation
Shunlei Duan & Guohong Yuan & Xiaomeng Liu & Ruotong Ren & Jingyi Li & Weizhou Zhang & Jun Wu & Xiuling Xu & Lina Fu & Ying Li & Jiping Yang & Weiqi Zhang & Ruijun Bai & Fei Yi & Keiichiro Suzuki & Hu, 2015.
"PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype,"
Nature Communications, Nature, vol. 6(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms10068
DOI: 10.1038/ncomms10068
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms10068. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.